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Abstract: Mortality represents an important outcome measure following coronary artery 
bypass grafting. Shorter survival times may reflect poor surgical quality and an increased 
number of costly postoperative complications. Quality control efforts aimed at increasing 
survival times may be misleading if not properly adjusted for case-mix severity. This paper 
demonstrates how to construct and cross-validate efficiency-outcome plots for a specified 
time (e.g., 6-month and 1-year survival) after coronary artery bypass grafting, accounting 
for baseline cardiovascular risk factors. The application of this approach to regional centers 
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allows  for  the  localization  of  risk  stratification  rather  than  applying  overly  broad  and  
non-specific models to their patient populations. 
Keywords: outcomes; coronary artery bypass grafting; CABG; survival; mortality 
 
1. Introduction 
Current  models  to  predict  outcomes  after  coronary  artery  bypass  grafting  (CABG)  have  been 
developed using statewide and national data [1,2]. However, predicted survival estimates from these 
databases tend to focus on hospitals in large urban areas, missing many rural regions with racially and 
economically diverse populations. Furthermore, prediction models are more likely to perform poorly 
when applied to groups or regions other than those in which they were derived. 
Models customized for regional centers or specific areas with unique patient populations are known 
to perform better than generalized models developed using patient data that is unrepresentative of the 
targeted  population  [3].  Accordingly,  localized  models  are  important  for  physicians  to  optimize 
individual  postoperative  care  and  to  appropriately  inform  patients  of  their  likelihood  of  survival  
after surgery. 
The development and application of individual institution quality measurements allow for constant 
evaluation  and  outcome  improvement.  To  aid  surgeons  and  centers,  we  have  developed  a  simple 
graphical technique to examine risk-adjusted survival estimates that account for case-mix severity. 
This  technique,  displayed  as  efficiency-outcome  plots,  enables  regional  centers  to  examine  their 
outcomes  over  contiguous  time  periods.  It  also  fills  an  important  gap  in  the  quality  assessment 
literature (e.g., graphical tools for monitoring surgical performance) by taking into account censored, 
time-to-event data. In this paper, we present the application of this graphical procedure with data from 
a large tertiary referral heart institute. 
2. Experimental Section 
The  Institutional  Review  Board  at  the  Brody  School  of  Medicine,  East  Carolina  University, 
approved the analysis. Details of the database have been previously described and are summarized 
below [4–12]. 
2.1. Patients and Variables 
The data used in this example analysis included patients undergoing first-time, isolated CABG at 
the  East  Carolina  Heart  Institute  between  1  January  2001  and  31  December  2008.  Patients  were 
categorized  into  2-year  increments  by  date  of  surgery.  Demographic  data,  comorbid  conditions, 
coronary  artery  disease  (CAD)  severity,  and  surgical  data  were  collected  at  the  time  of  surgery.  
The  analysis  was  restricted  to  black  and  white  patients  to  minimize  the  potential  for  residual 
confounding (~1% other races). Racial identity was self-reported. Emergent cases were considered to 
have a different etiology following surgery and were excluded in our example (n = 97). 
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2.2. Definitions 
Mortality was defined as any cause of death postoperatively. CAD was defined as ≥50% stenosis 
and  confirmed  by  angiography  before  surgery.  Postoperative  complications  including  operative 
mortality were defined as occurring within 30 days following CABG in or out of our hospital and after 
30 days during the same hospitalization following surgery. 
2.3. Setting 
The  East  Carolina  Heart  Institute  is  a  tertiary  care,  population-based  heart  hospital  located  in 
eastern North Carolina, a rural region with a large economically impoverished population  [4–12].  
The institute is the largest stand-alone facility devoted to cardiovascular care in the state of North 
Carolina. Cardiovascular disease is the leading cause of death in North Carolina with an unequal 
burden occurring in eastern North Carolina [13]. The majority of patients treated at the East Carolina 
Heart Institute live and remain within a 150-mile radius of the medical center. 
2.4. Data Collection and Follow-up 
The main sources of data were the Society of Thoracic Surgeons (STS) Adult Cardiac Surgery 
Database linked with the electronic medical record at the Brody School of Medicine. The National 
Death Index was used to obtain death dates for patients lost to follow-up and also used to validate 
death information collected in our electronic medical record. Linkage with the National Death Index 
was  performed  using  a  multiple  criteria,  deterministic  matching  algorithm  [14].  Less  than  5%  of 
validated  deaths  failed  to  correctly  match  with  the  National  Death  Index.  The  Epidemiology  and 
Outcomes  Research  Unit  at  the  East  Carolina  Heart  Institute  regularly  perform  data  quality  and  
cross-field validation. 
2.5. Statistical Analysis 
Categorical  variables  were  reported  as  frequency  and  percentage;  continuous  variables  were 
reported as mean (plus or minus 1 standard deviation), median, and range. Trend across time periods 
was assessed using the Cochran-Armitage test for binary variables and a standard linear regression test 
(Ho: β1 = 0) for continuous variables. For categorical variables with more than two stratification levels, 
a chi-square test for non-zero correlation was used to assess trend. 
Risk-adjusted survival estimates at 6 months and 1 year were computed using the multivariable 
product-limit method with date of surgery as the reference point [15]. Patients who were still alive at 
the date of last contact were censored. The family of product-limit models is known to have strong 
uniform consistency and other desirable statistical properties [16–18]. When there are no covariates, 
the  multivariable  product-limit  model  approximates  the  actuarial  survival  curve  [15,18,19].  
For  cross-validation  (model  performance),  we  computed  the  percentage  difference  of  fitted 
probabilities for each time period under the multivariable product-limit model to observe probabilities 
measured using standard survival curves. Percentage difference values within ± 2.5% were considered 
to be in the equivalence zone. A Wilcoxon-signed rank sum test was used to test the null hypothesis 
that the general measure of central tendency for the percentage differences did not differ from zero.  Int. J. Environ. Res. Public Health 2014, 11  7473 
 
 
The discriminate abilities of our models were assessed by examining estimated survival plots of key 
variables for risk group separation and also by computing the c-statistic concordance probability given 
censoring [20–22]. An interaction of model variables by time may affect overall fit and performance of 
the model. A test for this assumption was performed by including time-dependent covariates in our 
regression  model  [23].  The  models  included  variables  that  have  been  previously  reported  to  be 
associated  with  cardiovascular-related  mortality,  regardless  of  their  statistical  significance  in  our 
dataset [4–12]. These included age, sex, race, hypertension, CAD severity, heart failure, and prior 
stroke. Efficiency-outcome plots were generated to illustrate risk-adjusted survival by time period. 
Statistical significance was defined as p ≤ 0.05. SAS Version 9.3 (SAS Institute: Cary, NC, USA) was 
used for all analyses. 
3. Results and Discussion 
3.1. Results 
A total of 4639 patients underwent CABG between 2001  and 2008. Patient characteristics and 
postoperative complications stratified by time periods are shown in Tables 1 and 2, respectively. 
Table 1. Patient characteristics (N = 4639). 
Characteristic 
2001–2002 
n (%) 
2003–2004 
n (%) 
2005–2006 
n (%) 
2007–2008 
n (%) 
PTrend 
Overall  1574 (13)  1147 (9)  984 (8)  934 (7)  - 
Age, Mean ±  SD  64 ±  11  64 ±  10  64 ±  10  63 ±  10  0.23 
† 
Male Sex  1094 (70)  812 (71)  712 (72)  695 (74)  0.0062 
* 
White Race  1268 (81)  923 (80)  785 (80)  709 (76)  0.010 
* 
BMI (mg/kg
2), Mean ±  SD  29 ±  5.6  30 ±  5.9  30 ±  5.8  30 ±  5.9  0.23 
† 
Elective Surgery  706 (45)  741 (65)  466 (47)  382 (41)  0.0050 
CAD Severity 
     1 Vessel 
     2 Vessel 
     3 Vessel 
103 (7) 
387 (25) 
1084 (69) 
75 (7) 
294 (26) 
778 (68) 
53 (5) 
228 (23) 
703 (71) 
76 (8) 
254 (27) 
604 (65) 
0.18 
†† 
Left Main Disease  280 (18)  284 (25)  343 (35)  245 (26)  <0.0001 
* 
Recent Smoker  424 (27)  356 (31)  301 (31)  322 (34)  0.0001 
* 
Hypertension  1220 (78)  886 (77)  805 (82)  832 (89)  <0.0001 
* 
Diabetes  592 (38)  436 (38)  368 (37)  405 (43)  0.017 
* 
Heart Failure  251 (16)  312 (27)  296 (30)  236 (25)  <0.0001 
* 
Dialysis  36 (2)  16 (1)  17 (2)  26 (3)  0.53 
* 
PAD  199 (13)  173 (15)  179 (18)  166 (18)  <0.0001 
* 
COPD  96 (6)  201 (18)  199 (20)  245 (26)  <0.0001 
* 
Prior Stroke  107 (7)  99 (9)  84 (9)  93 (10)  0.0067 
* 
Prior MI  691 (44)  541 (47)  455 (46)  470 (50)  0.0043 
* 
Prior PCI  307 (19)  257 (22)  244 (25)  238 (25)  0.0001 
* 
*  Cochran-Armitage  Trend  Test; 
†  Linear  Regression; 
††  Chi-square  Test  for  non-zero  Correlation.  
BMI = body mass index; CAD = coronary artery disease; COPD = chronic obstructive pulmonary disease; 
MI = myocardial infarction; PAD = peripheral arterial disease; PCI = percutaneous coronary intervention;  
SD = standard deviation. Int. J. Environ. Res. Public Health 2014, 11  7474 
 
 
Table 2. Postoperative complications (N = 4639). 
Complication 
2001–2002 
n (%) 
2003–2004 
n (%) 
2005–2006 
n (%) 
2007–2008 
n (%) 
PTrend 
* 
Myocardial Infarction  3 (<1)  3 (<1)  3 (<1)  3 (<1)  0.49 
Stroke  23 (1)  27 (2)  11 (1)  11 (1)  0.30 
ARDS  25 (2)  23 (2)  9 (1)  3 (<1)  0.0023 
Pneumonia  27 (2)  31 (3)  26 (3)  17 (2)  0.65 
Renal Failure  32 (2)  38 (3)  27 (3)  11 (1)  0.27 
Operative Mortality  46 (3)  41 (4)  25 (3)  13 (1)  0.018 
* Cochran-Armitage Trend Test; ARDS = acute respiratory distress syndrome. 
Efficiency-outcome  plots  of  6-month  and  1-year  risk-adjusted  survival  are  shown  in  Figures  1  
and 2, respectively. Six-month survival increased during the analysis period (2001–2002: adjusted 
survival = 92.9%, 95%CI = 91.1–94.8; 2007–2008: adjusted survival = 97.5%, 95%CI = 96.0–98.9).  
A similar trend was observed for 1-year survival estimates (2001–2002: adjusted survival = 91.1%, 
95%CI = 88.9–93.3; 2007–2008: adjusted survival = 96.3%, 95%CI = 94.4–98.3). 
Figure 1. Efficiency-Outcome (EO) plot of risk-adjusted survival at six months 
*. 
 
* 95% CI noted by horizontal bars. Estimates shown were adjusted for age, sex, race, CAD 
severity,  hypertension,  heart  failure,  and  prior  stroke.  CAD  =  coronary  artery  disease;  CI  = 
confidence interval. 
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Figure 2. Efficiency-Outcome (EO) plot of risk-adjusted survival at one year 
*. 
 
* 95% CI noted by horizontal bars. Estimates shown were adjusted for age, sex, race, CAD 
severity, hypertension, heart failure, and prior stroke. CAD = coronary artery disease; CI = 
confidence interval. 
Our model performed moderately well at differentiating patients who lived from those who died 
(Table 3). Furthermore, the overall percentage difference values for age, sex, race, CAD severity, 
hypertension, heart failure, and prior stroke were within the predefined equivalence region, indicating 
good model performance (Table 4). Although, statistically significant differences from the equivalence 
region were observed for sex and heart failure in the 2003–2004 time period, the maximum percentage 
differences for these variables were relatively small (sex: 3.9%; heart failure: 3.4%). Excluding these 
variables from the model did not substantively affect our adjusted survival estimates for this time 
period (6-month: 94.4%, 95%CI = 92.6–96.1; 1-year: 92.7%, 95%CI = 90.6–94.8). 
Table 3. C-statistic and 95% confidence interval. 
Year Period 
Number of 
Usable Pairs 
Number of 
Concordant Pairs 
Number of 
Discordant Pairs 
C-Statistic 
(95%CI) 
2001–2002  82,566  593,780  258,786  0.70 (0.62–0.77) 
2003–2004  324,328  214,520  109,798  0.66 (0.55–0.77) 
2005–2006  141,552  105,692  35,860  0.75 (0.59–0.88) 
2007–2008  88,635  60,128  28,507  0.68 (0.48–0.85) 
2001–2010  4,934,832  3,659,189  1,275,643  0.74 (0.69–0.79) 
CI = confidence interval. 
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Table 4. Differential cross-validation (model performance) for survival estimates. 
Characteristic (Levels) 
% Within Equivalence Region  
2001–2002  2003–2004  2005–2006  2007–2008  2001–2008 
Age (<65, ≥65)  100 
*  100 
*  100 
*  100 
*  100 
* 
Sex (Male, Female)  100 
*  85 
††  100 
*  94 
*  100 
* 
Race (Black, White)  100 
*  100 
*  100 
*  100 
*  100 
* 
CAD Severity (1, ≥2 vessels)  100 
*  100 
*  100 
*  100 
*  100 
* 
Hypertension (Yes, No)  100 
*  100 
*  100 
*  100 
*  100 
* 
Heart Failure (Yes, No)  100 
*   76 
††   100 
*  100 
*  100 
* 
Prior Stroke (Yes, No)  100 
*  94 
*  100 
*  100 
*  100 
* 
* p > 0.05; 
† p ≤ 0.05; 
†† p < 0.01. CAD = coronary artery disease. 
Statistically significant interactions by time were observed for sex (2003–2006) and heart failure 
(2003–2004) (Table 5). A sensitivity analysis removing these variables from the affected time periods 
did not substantially affect model estimates. 
Table 5. Test for interaction effects by time. 
Characteristic 
2001–2002  2003–2004  2005–2006  2007–2008  2001–2008 
χ
2  p-value  χ
2  p-value  χ
2  p-value  χ
2  p-value  χ
2  p-value 
Age  0.25  0.62  0.32  0.57  0.19  0.66  0.32  0.57  0.0007  0.98 
Sex  1.05  0.31  7.18  0.0074  8.1  0.0044  2.8  0.095  6.93  0.0085 
Race  3.0  0.084  0.85  0.36  1.4  0.24  0.0  0.99  2.23  0.14 
2-vessel CAD  0.13  0.72  0.29  0.59  0.042  0.84  0.25  0.62  0.052  0.82 
3-vessel CAD  0.28  0.60  0.17  0.68  0.69  0.41  0.043  0.84  0.53  0.47 
Hypertension  0.038  0.85  1.2  0.28  0.012  0.91  3.1  0.079  0.035  0.85 
Heart Failure  0.089  0.76  3.9  0.048  0.042  0.84  1.1  0.29  2.24  0.13 
Prior Stroke  0.17  0.68  0.089  0.77  0.26  0.61  1.7  0.19  0.22  0.64 
All Covariates  5.22  0.73  22  0.0046  12  0.16  9.1  0.33  15.84  0.045 
χ
2 = Chi-Square; CAD = coronary artery disease. 
3.2. Discussion 
Outcomes  research  is  important  for  detecting  performance  changes  and  implementing  quality 
improvements  when  necessary.  Additionally,  unwarranted,  costly,  and  potentially  harmful 
modifications to current clinical practice can be avoided. Focusing on patient-centered outcomes by 
incorporating  individual  risk  factors  and  disease  severity  enables  physicians  to  provide  relevant 
information to patients and other stakeholders such as family members and caretakers. This information is 
particularly valuable for patients and their medical team who must decide on the best strategy for 
managing their postoperative care. 
In  this  paper,  we  describe  a  simple  technique  to  visualize  risk-adjusted  survival  estimates  that 
account  for  differences  in  case-mix  severity.  The  application  of  this  approach  to  regional  centers 
allows for the localization of risk stratification rather than applying overly broad and non-specific 
models to their patient populations. Efficiency-outcome plots can be used to monitor performance over 
continuous time periods to visually gauge whether deviations in outcomes have occurred independent Int. J. Environ. Res. Public Health 2014, 11  7477 
 
 
of case-mix. While confidence intervals are provided, this technique primarily serves as a graphical 
tool  for  monitoring  quality  over  time.  In  the  example  provided  from  our  institution,  6-month  
and  1-year  risk-adjusted  survival  estimates  improved  for  each  consecutive  2-year  time  period,  
but  especially  between  2004  and  2005  (as  indicated  by  the  decreased  slope).  The  observed 
improvements  likely  were  attributable  to  better  postoperative  care  (e.g.,  timely  identification  and 
management of complications), provider specialization, and hospital-wide quality control efforts. 
Case-mix severity may change with time, potentially biasing the comparison of survival estimates 
between time  periods. This  was evident  in  our  data  as  more patients  in  consecutive  time  periods 
presented with a larger percentage of comorbid conditions (e.g., heart failure, diabetes, hypertension, 
prior  stroke,  and  prior  myocardial  infarction).  Comparing  performance  solely  on  the  basis  of  
crude-survival figures may be misleading, especially when patients have been artificially selected to 
improve surgical outcomes. Additionally, efficiency-outcome plots are able to detect improvements or 
deteriorations  after  process  changes  in  clinical  care  have  been  implemented.  Although  we  have 
provided an example of how to monitor survival after CABG, this technique is equally applicable to 
other surgical procedures and medical interventions. 
Prediction models for survival after CABG have recently been examined. A study using data from 
the  New  York  State  Cardiac  Surgery  Reporting  System  has  developed  a  model  for  observed  and 
predicted risk of death at years 1, 3, 5, and 7 after surgery [2]. However, data used in this analysis were 
specific to regions of New York and may have little interpretability to rural regions or other parts of 
the United States. Similarly, an analysis of data from the national STS Adult Cardiac Surgery Database 
has developed a risk prediction model for survival after CABG [1]. Notably, the applicability of this 
model to priority populations is limited as only 4% of the patients in this study were identified as 
black. The above studies highlight the shortcomings of applying generalized prediction models of 
survival to groups different from those in which they were originally constructed [3]. 
To date, several useful methods for plotting outcomes data (e.g., process charts, cumulative sum 
(CUSUM)  charts,  funnel  plots,  and  resetting  sequential  probability  ratio  test  (RSPRT)  charts)  to 
visually assess changes in risk over time for cardiovascular procedures have been presented in the 
literature  [24–26].  Typically,  these  procedures  have  relied  on  parametric  techniques  such  as  
likelihood-based  scoring  or  the  sequential  probability  ratio  test.  To  the  best  of  our  knowledge, 
efficiency-outcome plots represent a unique application for generating continuous risk adjusted plots 
that  account  for  censored  data,  independent  of  the  parametric  assumptions  that  underlie  other 
commonly used graphical methods for risk assessment [24–26]. Efficiency-outcome plots also have the 
distinct advantage of tailoring the demographics to the center being assessed. The plots are simple to 
interpret  and  are  easily  generated  using  standard  statistical  software  packages  that  compute 
multivariable product-limit survival probabilities. Furthermore, we have outlined how to cross-validate 
the model performance of efficiency-outcome plots using an equivalence region approach based on the 
percentage difference of fitted probabilities. 
In the example provided, intra- and postoperative management of CABG have improved within our 
center. This likely represents a similar trend observed at other cardiovascular surgical facilities across 
the United States. However, there could be exceptions, especially within rural regions, where a focus 
on quality improvement is not emphasized. The advantage of efficiency-outcome plots is that they are 
able to identify, in a timely manner, departures from the norm. This will enable health care institutions Int. J. Environ. Res. Public Health 2014, 11  7478 
 
 
to investigate the underlying cause of these changes and implement either reinforcing or corrective 
strategies.  Furthermore,  this  method  may  be  applied  to  other  performance-related  measures  
(e.g.,  patient  satisfaction,  return  to  work,  quality  of  life,  hospital  acquired  infections,  operative 
mortality, operative time). We chose 6-month and 1-year survival for illustration purposes only. 
Specifically,  the  focus  of  the  current  manuscript  was  on  introducing  this  novel  method  and 
providing our institution as an example. Given that the technique adjusts for case mix, the resulting 
plots may be compared between institutions as well. While, the latter is beyond the scope of the current 
study,  it  would  be  interesting  to  use  efficiency-outcome  plots  to  compare  performance  across 
institutions in a future study. 
3.3. Limitations 
The methodology described in our analysis has several limitations inherent to modeling censored 
survival  data  and  must  be  considered  when  applying  this  technique.  The  estimation  of  adjusted 
survival probabilities assumes that the relationship between the log cumulative hazard and a set of 
covariates must be approximately linear [15]. Furthermore, censoring must be non-informative (i.e., 
not related to the probability of an event occurring). The latter assumption poses a limitation for any 
time-to-event model and must be addressed in the design phase. In some cases, adding interaction 
terms (including time) to our model may be necessary when the underlying data seriously violate the 
parallel hazard assumption [23]. Additionally, redundant and highly correlative variables may lead to 
unstable estimates and should be avoided. 
Contextual  factors  including  surgeon  training,  experience,  caseload,  and  turnover  may  have 
explained differences in quality measures over time. However, adjusting for these factors in our model 
would have led to over-adjustment and possibly masked any underlying differences in institutional 
practice. This would have been counterintuitive to the purpose of our model, which is to monitor 
changes in healthcare performance independent of changes in patient characteristics (e.g., case-mix). 
Efficiency-outcome plots rely on semi-parametric survival analysis methodology and do not have a 
simple, closed mathematical form. Consequently, estimates are derived using an iterative computer 
algorithm. However, such algorithms are commonly available in most standard statistical packages. 
4. Conclusions 
In  this  paper,  we  describe  a  practical  technique  to  graphically  monitor  efficiency  of  care  and 
consequent  risk  over  time,  and  provide  an  example  of  how  this  model  can  be  used  in  the 
cardiovascular surgery setting to improve overall healthcare performance. Efficiency-outcome plots 
allow individual centers to continuously assess quality measures and determine when process changes 
result  in  improved  or  poorer  outcomes.  Future  research  may  benefit  from  active  surveillance  of 
morbidity and mortality following CABG to provide real-time quality measurements. 
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